2 results
Not approvedWill not start
To better understand the utilities of the new BETACONNECT device and characterize its contribution to adherence, we plan to prospectively follow-up MS patients using the device for 24 weeks.
Approved WMOPending
The objectives of this study are to evaluate: • the safety of VYC-25L injectable gel in subjects seeking to increase facial volume in the chin and jaw area • the performance of VYC-25L injectable gel in restoring and creating facial volume in the…